// App-Quantinova.ai

Mo1800 : Risk Factors for Serious Infections in Elderly Patients Receiving Infliximab and Other Crohns Disease Therapies: TR-Registry Data

Researchers

Presenter

Principal Investigators

  • N/A

Medical Centers

  • University of Pennsylvania, Philadelphia, Pennsylvania, United States

  • UC Davis, Davis, California, United States

  • Atlanta Gastroenterology Associates, Atlanta, Georgia, United States

  • University Illinois Chicago, Chicago, Illinois, United States

  • Robarts Reserach Institute, London, ON, Canada

Locations

  • United States

  • Canada

Companies

  • JB Medical Ltd.

  • Janssen Global Servi

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

  • Prednisone

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved